Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome

Pediatric Nephrology

Volumn 30, Issue 8, 2015, Pages 1279-1287

  Cil, Onur ^a   Besbas, Nesrin ^a   Duzova, Ali ^a   Topaloglu, Rezan ^a   Peco Antić, Amira ^b   Korkmaz, Emine ^a   Ozaltin, Fatih ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

Author keywords

Congenital nephrotic syndrome; Infantile nephrotic syndrome; LAMB2; NPHS1; NPHS2; WT1

Indexed keywords

ALBUMIN; IMMUNOSUPPRESSIVE AGENT; LAMB2 PROTEIN; NEPHRIN; PODOCIN; PROTEIN; SERUM ALBUMIN; UNCLASSIFIED DRUG; WT1 PROTEIN; LAMININ; LAMININ BETA2; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ARTICLE; CLINICAL EVALUATION; CONGENITAL DISORDER; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; EXON; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFANT; INFANTILE NEPHROTIC SYNDROME; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; SURVIVAL RATE; GENETIC ASSOCIATION; GENETICS; KAPLAN MEIER METHOD; MORTALITY; NEWBORN; NUCLEOTIDE SEQUENCE; ONSET AGE; TUMOR SUPPRESSOR GENE;

AGE OF ONSET; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, WILMS TUMOR; GENETIC ASSOCIATION STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; LAMININ; MALE; MEMBRANE PROTEINS; NEPHROTIC SYNDROME; PROGNOSIS;

EID: 84933177902     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-015-3058-x     Document Type: Article

References (42)

1. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639
2. Machuca E, Benoit G, Antignac C (2009) Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology. Hum Mol Genet 18:R185–R194
3. Benoit G, Machuca E, Antignac C (2010) Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations. Pediatr Nephrol 25:1621–1632
4. Jalanko H (2009) Congenital nephrotic syndrome. Pediatr Nephrol 24:2121–2128
5. Zenker M, Machuca E, Antignac C (2009) Genetics of nephrotic syndrome: new insights into molecules acting at the glomerular filtration barrier. J Mol Med 87:849–857
6. Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, Arbeitsgemeinschaft für Paediatrische Nephrologie Study Group (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907–e919
7. Mucha B, Ozaltin F, Hinkes BG, Hasselbacher K, Ruf RG, Schultheiss M, Hangan D, Hoskins BE, Everding AS, Bogdanovic R, Seeman T, Hoppe B, Hildebrandt F, Members of the APN Study Group (2006) Mutations in the Wilms’ tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 59:325–331
8. Machuca E, Benoit G, Nevo F, Tête MJ, Gribouval O, Pawtowski A, Brandström P, Loirat C, Niaudet P, Gubler MC, Antignac C (2010) Genotype–phenotype correlations in Non-Finnish congenital nephrotic syndrome. J Am Soc Nephrol 21:1209–1217
9. Santín S, Bullich G, Tazón-Vega B, García-Maset R, Giménez I, Silva I, Ruíz P, Ballarín J, Torra R, Ars E (2011) Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 6:1139–1148
10. Gbadegesin R, Hinkes BG, Hoskins BE, Vlangos CN, Heeringa SF, Liu J, Loirat C, Ozaltin F, Hashmi S, Ulmer F, Cleper R, Ettenger R, Antignac C, Wiggins RC, Zenker M, Hildebrandt F (2008) Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 23:1291–1297
11. Brown EJ, Pollak MR, Barua M (2014) Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney Int 85:1030–1038
12. Ozaltin F (2014) Primary coenzyme Q10 (CoQ10) deficiencies and related nephropathies. Pediatr Nephrol 29:961–969
13. Koziell A, Grech V, Hussain S, Lee G, Lenkkeri U, Tryggvason K, Scambler P (2002) Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet 11:379–388
14. Cialone J, Adams H, Augustine E, Marshall F, Kwon J, Newhouse N, Vierhile A, Levy E, Dure L, Rose K, Ramirez-Montealegre D, de Blieck E, Mink J (2012) Females experience a more severe disease course in batten disease. J Inherit Metab Dis 35:549–555
15. Sweezey NB, Ratjen F (2014) The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol 49:309–317
16. Philippe A, Nevo F, Esquivel EL, Reklaityte D, Gribouval O, Tête MJ, Loirat C, Dantal J, Fischbach M, Pouteil-Noble C, Decramer S, Hoehne M, Benzing T, Charbit M, Niaudet P, Antignac C (2008) Nephrin mutations Can cause childhood-onset steroid-resistant nephrotic syndrome. J Am Soc Nephrol 19:1871–1878
17. Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J, Hasselbacher K, Ozaltin F, Hildebrandt F, APN Study Group (2008) Specific podocin mutations correlate with Age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 19:365–371
18. Matejas V, Hinkes B, Alkandari F, Al-Gazali L, Annexstad E, Aytac MB, Barrow M, Bláhová K, Bockenhauer D, Cheong HI, Maruniak-Chudek I, Cochat P, Dötsch J, Gajjar P, Hennekam RC, Janssen F, Kagan M, Kariminejad A, Kemper MJ, Koenig J, Kogan J, Kroes HY, Kuwertz-Bröking E, Lewanda AF, Medeira A, Muscheites J, Niaudet P, Pierson M, Saggar A, Seaver L, Suri M, Tsygin A, Wühl E, Zurowska A, Uebe S, Hildebrandt F, Antignac C, Zenker M (2010) Mutations in the human laminin β2 (LAMB2) gene and the associated phenotypic spectruma. Hum Mutat 31:992–1002
19. Chernin G, Vega-Warner V, Schoeb DS, Heeringa SF, Ovunc B, Saisawat P, Cleper R, Ozaltin F, Hildebrandt F, Members of the GPN Study Group (2010) Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations. Clin J Am Soc Nephrol 5:1655–1662
20. Tuncbilek E (2001) Clinical outcomes of consanguineous marriages in Turkey. Turk J Pediatr 43:277–279
21. Tuncbílek E, Koc I (1994) Consanguineous marriage in Turkey and its impact on fertility and mortality. Ann Hum Genet 58:321–329
22. Kovacevic L, Reid CD, Rigden SA (2003) Management of congenital nephrotic syndrome. Pediatr Nephrol 18:426–430
23. Holmberg C, Antikainen M, Rönnholm K, Ala-Houhala M, Jalanko H (1995) Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 9:87–93
24. Frishberg Y, Feinstein S, Rinat C, Becker-Cohen R, Lerer I, Raas-Rothschild A, Ferber B, Nir A (2006) The heart of children with steroid-resistant nephrotic syndrome: is it all podocin? J Am Soc Nephrol 17:227–231
25. Velecela V, Lettice LA, Chau Y-Y, Slight J, Berry RL, Thornburn A, Gunst QD, van den Hoff M, Reina M, Martínez FO, Hastie ND, Martínez-Estrada OM (2013) WT1 regulates the expression of inhibitory chemokines during heart development. Hum Mol Genet 22:5083–5095
26. Wagner N, Morrison H, Pagnotta S, Michiels J-F, Schwab Y, Tryggvason K, Schedl A, Wagner K-D (2011) The podocyte protein nephrin is required for cardiac vessel formation. Hum Mol Genet 20:2182–2194
27. Heeringa SF, Vlangos CN, Chernin G, Hinkes B, Gbadegesin R, Liu J, Hoskins BE, Ozaltin F, Hildebrandt F, Members of the APN Study Group (2008) Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome. Nephrol Dial Transplant 23:3527–3533
28. Schoeb DS, Chernin G, Heeringa SF, Matejas V, Held S, Vega-Warner V, Bockenhauer D, Vlangos CN, Moorani KN, Neuhaus TJ, Kari JA, MacDonald J, Saisawat P, Ashraf S, Ovunc B, Zenker M, Hildebrandt F, Gesselschaft für Paediatrische Nephrologie (GPN) Study Group (2010) Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS). Nephrol Dial Transplant 25:2970–2976
29. Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582
30. Lenkkeri U, Männikkö M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac CK, Kashtan CE, Homberg C, Olsen A, Kestilä M, Tryggvason K (1999) Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64:51–61
31. Beltcheva O, Martin P, Lenkkeri U, Tryggvason K (2001) Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat 17:368–373
32. Gigante M, Monno F, Roberto R, Laforgia N, Assael MB, Livolti S, Caringella A, La Manna A, Masella L, Iolascon A (2002) Congenital nephrotic syndrome of the Finnish type in Italy: a molecular approach. J Nephrol 15:696–702
33. Tikhomirov E, Averyanova N, Bayazutdinova G, Voznesenskaya T, Tsygin A (2007) Novel human pathological mutations. Gene symbol: NPHS2, disease: streoid-resistant nephrotic syndrome. Hum Genet 122:545–559
34. Weber S, Gribouval O, Esquivel EL, Morinière V, Tête MJ, Legendre C, Niaudet P, Antignac C (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and lowpost-transplant recurrence. Kidney Int 66:571–579
35. Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM (2001) Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12:2742–2746
36. Tonna SJ, Needham A, Polu K, Uscinski A, Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, Savige J, Harmon J, Zhang K, Curhan GC, Pollak MR (2008) NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol 9:13
37. Bouchireb K, Boyer O, Gribouval O, Nevo F, Huynh-Cong E, Morinière V, Campait R, Ars E, Brackman D, Dantal J, Eckart P, Gigante M, Lipska BS, Liutkus A, Megarbane A, Mohsin N, Ozaltin F, Saleem MA, Schaefer F, Soulami K, Torra R, Garcelon N, Mollet G, Dahan K, Antignac C (2014) NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum. Hum Mutat 35:178–186
38. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–354
39. Hakan N, Aydin M, Erdogan O, Cavusoglu YH, Aycan Z, Ozaltin F, Zenciroglu A, Apaydin S, Gunes R, Sahin G, Cinar G, Okumus N (2012) A novel WT1 gene mutation in a newborn infant diagnosed with Denys-Drash syndrome. Genet Couns 23:255–261
40. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447
41. Kikuchi H, Takata A, Akasaka Y, Fukuzawa R, Yoneyama H, Kurosawa Y, Honda M, Kamiyama Y, Hata J (1998) Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome? J Med Genet 35:45–48
42. Aydin B, Ipek MS, Ozaltin F, Zenciroğlu A, Dilli D, Beken S, Okumuş N, Hoşağasi N, Saygili-Karagöl B, Kundak A, Renda R, Aydog O (2013) A novel mutation of laminin β-2 gene in Pierson syndrome manifested with nephrotic syndrome in the early neonatal period. Genet Couns 24:141–147